Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma.
Wesson W, Dima D, Suleman N, Saif MSI, Tabak C, Logan E, Davis JA, McGann M, Furqan F, Mohan M, Rashid A, Abdallah AO, Ullah F, Shune L, Mushtaq MU, Raza S, McGuirk J, Hamadani M, Anwer F, Hashmi H, Ahmed N.
Wesson W, et al. Among authors: suleman n.
Transplant Cell Ther. 2024 Sep;30(9):876-884. doi: 10.1016/j.jtct.2024.06.012. Epub 2024 Jun 11.
Transplant Cell Ther. 2024.
PMID: 38871056
Free article.